Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of STSG-0002 injection in previously treated chronic hepatitis B patients (Ib/II)
CTR20230449Phase 2Terminated
- Sponsor
- Sannuo Jiayi
- Start
- Feb 2023
- Modality
- Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of STSG-0002 in Chronic Hepatitis B (CHB), sponsored by Sannuo Jiayi. Started Feb 2023; status: terminated.
02
Drugs
STSG-0002
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20230449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230449.